Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 16
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05193279 | Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age | ||
| NCT06666179 | Safety and Immunogenicity Study of SCB-1019T in Children | ||
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | ||
| NCT05228314 | Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults | ||
| NCT03443674 | Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies | ||
| NCT04932824 | Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19. | ||
| NCT04919096 | Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration | ||
| NCT06567457 | Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults | ||
| NCT06194318 | First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults | ||
| NCT05012787 | Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases | ||
| NCT05188677 | Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults | ||
| NCT06984094 | First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults | ||
| NCT05926440 | Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults | ||
| NCT04672395 | A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 | ||
| NCT03869697 | Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions | ||
| NCT04950751 | Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults |
